Related Experiment Video
Updated: May 29, 2025

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model
Published on: November 6, 2020
Establishment of a Mouse Intravenous Challenge Model for Predicting Virulence in Yarrowia lipolytica Disseminated
Jinhan Yu1,2,3, Xueqing Liu4, Weixin Ke5
1Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.
Abstract:
Invasive fungal infections pose a significant health threat. Yarrowia lipolytica (formerly known as Candida lipolytica) is an opportunistic yeast with pathogenic potential, but its virulence and impact on the host remain poorly understood. This study aimed to investigate the infection characteristics associated with this relatively unknown pathogen by establishing reliable animal models. We developed intravenous challenge models in immunocompetent and immunosuppressed BALB/c mice by injecting fungal cells directly into the bloodstream. In immunocompetent mice, Y. lipolytica was effectively cleared even at the highest challenge dose of 1 × 10⁸ cells, resulting in minimal mortality. However, this clearance was accompanied by a significant elevation in peripheral blood cytokine levels. Three days post-infection, the fungal burden was highest in the lungs (P < 0.0001), followed by the spleen, kidneys, liver, and brain. In immunosuppressed mice, the mortality rate following Y. lipolytica infection significantly increased (P < 0.001), with the highest fungal burden consistently observed in the lungs. In the immunosuppressed model, clinical isolates exhibited a greater lung fungal burden compared to industrial isolate. In conclusion, Y. lipolytica is a low-virulence fungus that is challenging to establish as a fatal infection in immunocompetent hosts but exhibits a marked tropism for the lungs, where lung fungal burden serves as an effective indicator of virulence. This model may also provide critical insights for studying fungal pulmonary infection pathogenesis and the infection dynamics of Y. lipolytica, especially for immunocompromised patients.
Insights
Yarrowia lipolytica causes mild infections in healthy mice but targets the lungs in immunocompromised individuals. Lung fungal burden indicates virulence, offering insights into pulmonary fungal infections.
Area of Science:
- Mycology
- Immunology
- Infectious Diseases
Background:
- Invasive fungal infections represent a major global health concern.
- Yarrowia lipolytica, an opportunistic yeast, has pathogenic potential but its virulence is poorly understood.
- Understanding Y. lipolytica pathogenesis is crucial, especially for vulnerable populations.
Purpose of the Study:
- To investigate the infection characteristics of Yarrowia lipolytica.
- To establish reliable animal models for studying Y. lipolytica infections.
- To determine the impact of host immunity on Y. lipolytica virulence.
Main Methods:
- Intravenous challenge models were established in immunocompetent and immunosuppressed BALB/c mice.
- Fungal burden was assessed in various organs (lungs, spleen, kidneys, liver, brain).
- Mortality rates and peripheral blood cytokine levels were monitored.
Main Results:
- Y. lipolytica was cleared in immunocompetent mice with minimal mortality but elevated cytokines.
- In immunosuppressed mice, Y. lipolytica infection led to significantly increased mortality.
- The lungs consistently showed the highest fungal burden in both models, indicating pulmonary tropism.
Conclusions:
- Yarrowia lipolytica exhibits low virulence in immunocompetent hosts but can cause severe lung infections in immunosuppressed individuals.
- Lung fungal burden is a key indicator of Y. lipolytica virulence.
- The developed models provide valuable insights into fungal pulmonary infection and Y. lipolytica pathogenesis, particularly in immunocompromised patients.
More Related Videos
09:15A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
Published on: February 28, 2019
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022